Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
545 studies found for:    "Visceral steatosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Visceral steatosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Fatty Acids, Genes and Microbiota in Fatty Liver
Conditions: Nonalcoholic Fatty Liver Disease;   Steatosis;   Nonalcoholic Steatohepatitis
2 Recruiting Genetic Studies of Non-Alcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Liver Cirrhosis;   Non-Alcoholic Fatty Liver Disease;   Liver Transplantation;   Genetics
3 Completed Treatment of Nonalcoholic Steatohepatitis With Pioglitazone
Conditions: Fatty Liver;   Nonalcoholic Steatohepatitis
Intervention: Drug: Pioglitazone
4 Completed Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Steatohepatitis
Intervention: Drug: Spironolactone/Vitamin E
5 Unknown  An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis
Conditions: Psoriasis Chronic;   Liver Fibrosis;   Fatty Liver;   Non-alcoholic Fatty Liver Disease
Intervention: Device: Transient elastography
6 Recruiting Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steatosis
Conditions: Fatty Liver;   Hepatic Steatosis;   Liver Steatosis
Interventions: Device: FibroTouch;   Procedure: Liver Biopsy
7 Recruiting Fatty Liver Disease Collaborative Research in China
Conditions: Fatty Liver;   Fatty Liver, Alcoholic;   Non-alcoholic Fatty Liver Disease
8 Completed Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients
Conditions: Fatty Liver;   Steatohepatitis
Intervention: Drug: Rifaximin
9 Unknown  Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease in Diabetic Patients
Conditions: Nonalcoholic Fatty Liver Disease (NAFLD).;   Nonalcoholic Steatohepatitis.;   Diabetes.
Interventions: Procedure: Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG).;   Other: Low carbohydrate diet
10 Unknown  Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis;   Nonalcoholic Fatty Liver Disease
Interventions: Drug: avandia;   Drug: metformin;   Drug: losartan
11 Active, not recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin
12 Terminated
Has Results
Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections
Conditions: HIV;   Hepatitis C;   Liver Disease;   Fatty Liver;   Steatosis
Interventions: Drug: Pioglitazone;   Drug: Placebo
13 Completed Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Fatty Liver Disease;   Non-alcoholic Steatohepatitis
Intervention: Other: Omega-3 capsules-Fish Oil
14 Completed Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Steatohepatitis;   Fatty Liver
Interventions: Drug: Omega 3 Fish Oil supplements;   Drug: Placebo
15 Completed Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.
Conditions: Non-alcoholic Fatty Liver Disease;   Non-alcoholic Steatohepatitis
Intervention: Dietary Supplement: High oral Fructose challenge (150g per day for 28 days)
16 Recruiting Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Conditions: Non Alcoholic Fatty Liver Disease;   Steatohepatitis;   Hypertriglyceridemia;   Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1
Intervention: Other: Omega diet
17 Terminated
Has Results
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis (NASH);   Hepatic Steatosis
Interventions: Drug: Omega-3-acid ethyl esters (Lovaza);   Drug: Placebo
18 Completed Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth
Conditions: Hepatic Steatosis;   Fatty Liver
19 Completed Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis
Conditions: Non-Alcoholic Fatty Liver Disease;   Nonalcoholic Steatohepatitis;   Metabolic Syndrome
Interventions: Drug: Aramchol;   Drug: Placebo
20 Completed
Has Results
Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)
Conditions: Non-alcoholic Fatty Liver Disease;   Nonalcoholic Steatohepatitis
Interventions: Device: Tru-cut biopsy;   Procedure: Tru-cut

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years